The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
Open accessPublished version of a preprint
Abstract
Over the past 20 years, several coronaviruses have crossed the species barrier into humans, causing outbreaks of severe, and often fatal, respiratory illness. Since SARS-CoV was first identified in animal markets, global viromics projects have discovered thousands of coronavirus sequences in diverse animals and geographic regions. Unfortunately, there are few tools available to functionally test these viruses for their ability to infect humans, which has severely hampered efforts to predict the next zoonotic viral outbreak. Here, we developed an approach to rapidly screen lineage B betacoronaviruses, such as SARS-CoV and the recent SARS-CoV-2, for receptor usage and their ability to infect cell types from different species. We show that host protease processing during viral entry is a significant barrier for several lineage B viruses and that bypassing this barrier allows several lineage B viruses to enter human cells through an unknown receptor. We also demonstrate how different lineage B viruses can recombine to gain entry into human cells, and confirm that human ACE2 is the receptor for the recently emerging SARS-CoV-2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The S protein mediates binding of coronaviruses to angiotensin converting enzyme 2 (ACE2) on the surface of various cell types including epithelial cells of the pulmonary alveolus (4–6).”
From An Alphavirus -derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates (2020) · cites this paper as [5]
Experimental — accuracy not yet measuredIn the citing paper
“it directly interacts with the cellular receptor angiotensin converting enzyme 2 (ACE2) which mediates host cell entry”
From SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2 (2021) · cites this paper as Letko et al., 2020
In the citing paper
“SARS-CoV-2 is a single-stranded RNA β-coronavirus and a member of the subgenus Sarbecovirus (beta-CoV lineage B).”
From Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (2020) · cites this paper as Letko et al., 2020
In the citing paper
“It is the seventh member of the Coronaviridae known to infect humans so far, two of which, SARS-CoV and MERS-CoV, caused global health threats previously (Guarner, 2020; Letko et al., 2020).”
From Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (2020) · cites this paper as Letko et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020) · Journal of Virology · doi:10.1128/jvi.00127-20 · Cited by 4,341
Structure, Function, and Evolution of Coronavirus Spike Proteins
Li, F. (2016) · Annual Review of Virology · doi:10.1146/annurev-virology-110615-042301 · Cited by 2,740
Bats Are Natural Reservoirs of SARS-Like Coronaviruses
Li, W., Shi, Z., Yu, M., Ren, W., Smith, C. S., Epstein, J. H., Wang, H., Crameri, G. S., Hú, Z., Zhang, H., et al. (2005) · Science · doi:10.1126/science.1118391 · Cited by 2,571
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., et al. (2013) · Nature · doi:10.1038/nature12005 · Cited by 2,061
Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor
Li, F., Li, W., Farzan, M., & Harrison, S. C. (2005) · Science · doi:10.1126/science.1116480 · Cited by 2,035
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor
Ge, X.-Y., Li, J.-L., Yang, X.-L., Chmura, A. A., Zhu, G., Epstein, J. H., Mazet, J. K., Hu, B., Zhang, W., Peng, C., et al. (2013) · Nature · doi:10.1038/nature12711 · Cited by 1,778
Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats
Lau, S. K. P., Woo, P. C. Y., Li, K. S. M., Huang, Y. P., Tsoi, H., Wong, B. H. L., Wong, S. S. Y., Leung, S.-Y., Chan, K., & Yuen, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506735102 · Cited by 1,561
Belouzard, S., Chu, V. C., & Whittaker, G. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809524106 · Cited by 1,076
Cited by
Sorted by citations
Items 601–700 of 1,005
Hu, Z., Huang, X., Zhang, J., Fu, S., Ding, D., & Tao, Z. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.792135 · Cited by 66
Pormohammad, A., Zarei, M., Ghorbani, S., Mohammadi, M., Neshin, S. A. S., Khatami, A., Turner, D., Djalalinia, S., Mousavi, S. A., Mardani-Fard, H. A., et al. (2021) · Vaccines · doi:10.3390/vaccines10010023 · Cited by 60
He, W., Musharrafieh, R. G., Song, G., Dueker, K., Tse, L. V., Martinez, D. R., Schäfer, A., Callaghan, S., Yong, P., Beutler, N., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01222-1 · Cited by 58
Martins, M., do Nascimento, G. M., Nooruzzaman, M., Yuan, F., Chen, C., Caserta, L. C., Miller, A. D., Whittaker, G. R., Fāng, Y., & Diel, D. G. (2022) · Journal of Virology · doi:10.1128/jvi.00961-22 · Cited by 62
Potential Benefits and Harms of Novel Antidiabetic Drugs During COVID-19 Crisis
Mirabelli, M., CHIEFARI, E. D., Puccio, L., FOTI, D. P., & Brunetti, A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17103664 · Cited by 64
Hondermarck, H., Bartlett, N. W., & Nurcombe, V. (2020) · FASEB BioAdvances · doi:10.1096/fba.2020-00015 · Cited by 61
New Insights Into the Physiopathology of COVID-19: SARS-CoV-2-Associated Gastrointestinal Illness
Devaux, C. A., Lagier, J., & Raoult, D. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.640073 · Cited by 62
Ünal, M. A., Bitirim, C. V., Summak, G. Y., Bereketoğlu, S., Zeytin, İ. C., Beşbinar, Ö., Gürcan, C., Aydos, D., Göksoy, E., Kocakaya, E., et al. (2021) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2020-0734 · Cited by 64
Zhang, Z., Zeng, E., Zhang, L., Wang, W., Jin, Y., Sun, J., Huang, S., Yin, W., Dai, J., Zhuang, Z., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00302-0 · Cited by 60
Agrawal, P. K., Agrawal, C., & Blunden, G. (2021) · Natural Product Communications · doi:10.1177/1934578x211042540 · Cited by 64
Ikemura, N., Taminishi, S., Inaba, T., Arimori, T., Motooka, D., Katoh, K., Kirita, Y., Higuchi, Y., Li, S., Suzuki, T., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abn7737 · Cited by 62
Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019 (COVID-19)
Dixon, D. L., Tassell, B. W. V., Vecchié, A., Bonaventura, A., Talasaz, A. H., Kakavand, H., D'Ascenzo, F., Perciaccante, A., Castagno, D., Ammirati, E., et al. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000836 · Cited by 61
Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design
Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020) · Vaccines · doi:10.3390/vaccines8030355 · Cited by 60
Pigs are not susceptible to SARS‐CoV‐2 infection but are a model for viral immunogenicity studies
Vergara‐Alert, J., Rodon, J., Carrillo, J., Te, N., Izquierdo‐Useros, N., de la Concepción, M. L. R., Ávila‐Nieto, C., Guallar, V., Valencia, A., Cantero, G., et al. (2020) · Transboundary and Emerging Diseases · doi:10.1111/tbed.13861 · Cited by 57
Severe acute kidney injury in critically ill COVID-19 patients
Piñeiro, G. J., Andújar, A. M., Hermida, E., Blasco, M., Quintana, L. F., Muñoz-Rojas, G., Mercadal, J., Castro, P., Sandoval, E., Andrea, R., et al. (2021) · Journal of Nephrology · doi:10.1007/s40620-020-00918-7 · Cited by 60
Brogna, C., Simone, C., Marino, G., Montano, L., Viduto, V., Fabrowski, M., Lettieri, G., & Piscopo, M. (2023) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.202300048 · Cited by 71
Acıoğlu, Ç., & Elkabes, S. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03360-3 · Cited by 67
SARS-CoV, MERS-CoV, and 2019-nCoV viruses: an overview of origin, evolution, and genetic variations
Krishnamoorthy, S., Swain, B., Verma, R. S., & Gunthe, S. S. (2020) · VirusDisease · doi:10.1007/s13337-020-00632-9 · Cited by 63
Transmission of SARS-CoV-2 from humans to animals and potential host adaptationPreprint
Tan, C. C. S., Lam, S. D., Richard, D., Owen, C. J., Berchtold, D., Orengo, C. A., Nair, M. S., Kuchipudi, S. V., Kapur, V., van Dorp, L., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.16.384743 · Cited by 62
International Expansion of a Novel SARS-CoV-2 Mutant
Wang, M., Li, M., Ren, R., Bråve, A., van der Werf, S., Chen, E.-Q., 宗志勇, Li, W., & Ying, B. (2020) · Journal of Virology · doi:10.1128/jvi.00567-20 · Cited by 59
Classical and alternative receptors for SARS‐CoV‐2 therapeutic strategy
Masre, S. F., Jufri, N. F., Ibrahim, F. W., & Raub, S. H. A. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2207 · Cited by 62
Microarray patches enable the development of skin-targeted vaccines against COVID-19
Korkmaz, E., Balmert, S. C., Sumpter, T. L., Carey, C. D., Erdös, G., & Falo, L. D. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.022 · Cited by 60
de Melo, C. M. L., Silva, G. A. D. S., Melo, A. R. D. S., & de Freitas, A. C. (2020) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202020200709 · Cited by 59
Patel, C., Kumar, S. P., Pandya, H. A., & Rawal, R. (2020) · Molecular Diversity · doi:10.1007/s11030-020-10135-w · Cited by 60
Genome-wide CRISPR screen reveals host genes that regulate SARS-CoV-2 infectionPreprint
Wei, J., Alfajaro, M. M., Hanna, R. E., DeWeirdt, P. C., Strine, M. S., Lu-Culligan, W. J., Zhang, S., Graziano, V. R., Schmitz, C. O., Chen, J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.16.155101 · Cited by 59
Human organ chip-enabled pipeline to rapidly repurpose therapeutics during viral pandemicsPreprint
Si, L., Bai, H., Rodas, M. J., Cao, W., Oh, C. Y., Jiang, A. R., Møller, R., Hoagland, D. A., Oishi, K., Horiuchi, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.13.039917 · Cited by 59
Banerjee, A., Santra, D., & Maiti, S. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02435-4 · Cited by 58
Cell and animal models of SARS-CoV-2 pathogenesis and immunity
Leist, S. R., Schäfer, A., & Martinez, D. R. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.046581 · Cited by 55
Tizaoui, K., Zidi, I., Lee, K. H., Ghayda, R. A., Hong, S. H., Li, H., Smith, L., Koyanagi, A., Jacob, L., Kronbichler, A., et al. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.48812 · Cited by 57
SARS-CoV-2 variants reveal features critical for replication in primary human cells
Pohl, M. O., Busnadiego, I., Kufner, V., Glas, I., Karakus, U., Schmutz, S., Zaheri, M., Abela, I. A., Trkola, A., Huber, M., et al. (2021) · PLoS Biology · doi:10.1371/journal.pbio.3001006 · Cited by 55
Zinc-Embedded Polyamide Fabrics Inactivate SARS-CoV-2 and Influenza A Virus
Gopal, V., Nilsson-Payant, B. E., French, H., Siegers, J. Y., Yung, W., Hardwick, M. J., & Velthuis, A. J. W. T. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c04412 · Cited by 58
Khan, A., Wei, D., Kousar, K., Abubaker, J. A., Ahmad, S., Ali, J., Al‐Mulla, F., Ali, S. S., Nizam‐Uddin, N., Sayaf, A. M., et al. (2021) · ChemBioChem · doi:10.1002/cbic.202100191 · Cited by 59
Feldman, J. E., Bals, J., Altomare, C. G., Denis, K. S., Lam, E. C., Hauser, B. M., Ronsard, L., Sangesland, M., Moreno, T. B., Okonkwo, V., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abl5842 · Cited by 60
The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants
Rothenberger, S., Hurdiss, D. L., Walser, M., Malvezzi, F., Mayor, J., Ryter, S., Moreno, H., Liechti, N., Bosshart, A., Iss, C., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01382-3 · Cited by 75
Nanomedicine strategies to target coronavirus
Heinrich, M. A., Martina, B. E. E., & Prakash, J. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100961 · Cited by 60
Moreira, R. A., Guzman, H. V., Boopathi, S., Baker, J. L., & Poma, A. B. (2020) · Materials · doi:10.3390/ma13235362 · Cited by 61
“Update vision on COVID-19: Structure, immune pathogenesis, treatment and safety assessment”
Agrahari, R., Mohanty, S., Vishwakarma, K., Nayak, S. K., Samantaray, D., & Mohapatra, S. (2020) · Sensors International · doi:10.1016/j.sintl.2020.100073 · Cited by 57
Nanotechnology-Based Approaches for the Detection of SARS-CoV-2
Gupta, R., Sagar, P., Priyadarshi, N., Kaul, S., Sandhir, R., Rishi, V., & Singhal, N. K. (2020) · Frontiers in Nanotechnology · doi:10.3389/fnano.2020.589832 · Cited by 59
Pseudoviruses for the assessment of coronavirus disinfection by ozone
Zucker, I., Lester, Y., Alter, J., Werbner, M., Yecheskel, Y., Gal-Tanamy, M., & Dessau, M. A. (2021) · Environmental Chemistry Letters · doi:10.1007/s10311-020-01160-0 · Cited by 57
Placental response to maternal SARS-CoV-2 infection
Mourad, M., Jacob, T., Sadovsky, E., Bejerano, S., Simone, G. S.-D., Bagalkot, T. R., Zucker, J. E., Yin, M. T., Chang, J. Y., Liu, L., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-93931-0 · Cited by 58
Alimoradi, N., Sharqi, M., Firouzabadi, D., Sadeghi, M. M., Moezzi, S. M. I., & Firouzabadi, N. (2022) · Virology Journal · doi:10.1186/s12985-022-01782-6 · Cited by 61
Xu, T., Gao, X., Wu, Z., Selinger, D. W., & Zhou, Z. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.01.017624 · Cited by 57
Blaess, M. F., Kaiser, L., Sauer, M., Csük, R., & Deigner, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144953 · Cited by 57
Barochiner, J., & Martínez, R. (2020) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13246 · Cited by 56
Holly, J. M. P., Biernacka, K. M., Maskell, N. A., & Perks, C. M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.582870 · Cited by 56
COVID-19: Targeting Proteases in Viral Invasion and Host Immune Response
Seth, S., Batra, J., & Srinivasan, S. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00215 · Cited by 56
Mutational spectra of SARS-CoV-2 isolated from animals
Elaswad, A., Fawzy, M., Basiouni, S., & Shehata, A. A. (2020) · PeerJ · doi:10.7717/peerj.10609 · Cited by 58
Patil, R. B., Chikhale, R. V., Khanal, P., Gurav, N. S., Ayyanar, M., Sinha, S. K., Prasad, S. K., Dey, Y. N., Wanjari, M., & Gurav, S. S. (2020) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2020.100504 · Cited by 57
Precision therapeutic targets for COVID-19
Krumm, Z. A., Lloyd, G. M., Francis, C. P., Nasif, L. H., Mitchell, D. A., Golde, T. E., Giasson, B. I., & Xia, Y. (2021) · Virology Journal · doi:10.1186/s12985-021-01526-y · Cited by 58
Bracquemond, D., & Muriaux, D. M. (2021) · mBio · doi:10.1128/mbio.02371-21 · Cited by 52
A chitosan-mediated inhalable nanovaccine against SARS-CoV-2
Zhuo, S., Wu, J., Zhao, L., Li, W., Zhao, Y., & Li, Y. (2022) · Nano Research · doi:10.1007/s12274-021-4012-9 · Cited by 56
Focosi, D., Maggi, F., Mazzetti, P., & Pistello, M. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2170 · Cited by 59
Evidence for SARS-CoV-2 Spike Protein in the Urine of COVID-19 Patients
George, S., Pal, A. C., Gagnon, J., Timalsina, S., Singh, P., Vydyam, P., Munshi, M., Chiu, J. E., Renard, I., Harden, C. A., et al. (2021) · Kidney360 · doi:10.34067/kid.0002172021 · Cited by 56
Noorimotlagh, Z., Karami, C., Mirzaee, S. A., Kaffashian, M. R., Mami, S., & Azizi, M. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106738 · Cited by 55
Tomaszewski, T., DeVries, R. S., Dong, M., Bhatia, G., Norsworthy, M. D., Zheng, X., & Caetano‐Anollés, G. (2020) · Evolutionary Bioinformatics · doi:10.1177/1176934320965149 · Cited by 57
Awadasseid, A., Wu, Y., Tanaka, Y., & Zhang, W. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.47827 · Cited by 56
FBA reveals guanylate kinase as a potential target for antiviral therapies against SARS-CoV-2
Renz, A., Widerspick, L., & Dräger, A. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa813 · Cited by 56
Rosenfeld, R., Noy-Porat, T., Mechaly, A., Makdasi, E., Levy, Y., Alcalay, R., Falach, R., Aftalion, M., Epstein, E., Gur, D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21239-8 · Cited by 55
Fischer, R. J., Purushotham, J. N., van Doremalen, N., Sebastian, S., Meade-White, K. D., Cordova, K., Letko, M. C., Matson, M. J., Feldmann, F., Haddock, E., et al. (2021) · npj Vaccines · doi:10.1038/s41541-021-00291-x · Cited by 55
Self-citationPathogenesis of taste impairment and salivary dysfunction in COVID-19 patients
Okada, Y., Yoshimura, K., Toya, S., & Tsuchimochi, M. (2021) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2021.07.001 · Cited by 56
Pokhrel, S., Bouback, T. A., Samad, A., Nur, S. M., Alam, R., Abdullah-Al-Mamun, M., Nain, Z., Imon, R. R., Talukder, M. E. K., Tareq, M. M. I., et al. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.09.146 · Cited by 57
Moubarak, M., Kasozi, K. I., Hetta, . F., Shaheen, H. M., Rauf, A., Al-Kuraishy, H. M., Qusti, S. Y., Alshammari, E. M., Ayikobua, E. T., Ssempijja, F., et al. (2021) · Life · doi:10.3390/life11080734 · Cited by 57
Off-the-shelf CAR natural killer cells secreting IL-15 target spike in treating COVID-19
Lu, T., Ma, R., Dong, W., Teng, K., Kollath, D. S., Li, Z., Yi, J., Bustillos, C. G., Ma, S., Tian, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30216-8 · Cited by 59
Feng, Z., Wang, Y., & Qi, W. (2020) · Preprints.org · doi:10.20944/preprints202003.0161.v1 · Cited by 56
Bats, pangolins, minks and other animals - villains or victims of SARS-CoV-2?
do Vale, B., Lopes, A. P., Fontes, M. D. C., Silvestre, A. M., Cardoso, L., & Coelho, A. C. (2021) · Veterinary Research Communications · doi:10.1007/s11259-021-09787-2 · Cited by 55
Zdanowski, W., & Waśniewski, T. (2021) · Vaccines · doi:10.3390/vaccines9060675 · Cited by 55
Megyeri, K., Dernovics, Á., Al-Luhaibi, Z. I. I., & Rosztoczy, A. I. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i23.3208 · Cited by 57
Cell Death in Coronavirus Infections: Uncovering Its Role during COVID-19
Paolini, A., Borella, R., Biasi, S. D., Neroni, A., Mattioli, M., Tartaro, D. L., Simonini, C., Franceschini, L., Cicco, G., Piparo, A. M., et al. (2021) · Cells · doi:10.3390/cells10071585 · Cited by 55
Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2
Park, J.-G., Oladunni, F. S., Rohaim, M. A., Whittingham‐Dowd, J., Tollitt, J., Hodges, M., Fathallah, N., Assas, M. B., Alhazmi, W. A., Almilaibary, A., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102941 · Cited by 54
COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country
Licciardi, F., Giani, T., Baldini, L., Favalli, E. G., Caporali, R. F., & Cimaz, R. (2020) · Pediatric Rheumatology · doi:10.1186/s12969-020-00422-z · Cited by 53
Neurologic complications of COVID-19
Hassett, C. E., Gedansky, A., Migdady, I., Bhimraj, A., Uchino, K., & Cho, S. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87a.ccc058 · Cited by 55
Takahashi, Y., Hayakawa, A., Sano, R., Fukuda, H., Harada, M., Kubo, R., Okawa, T., & Kominato, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-82970-2 · Cited by 53
The way of SARS-CoV-2 vaccine development: success and challenges
Dong, Y., Dai, T., Wang, B., Zhang, L., Zeng, L., Huang, J., Yan, H., Zhang, L., & Zhou, F. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00796-w · Cited by 53
Lombardi, A., Butta, G. M., Donnici, L., Bozzi, G., Oggioni, M., Bono, P., Matera, M., Consonni, D., Ludovisi, S., Muscatello, A., et al. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100287 · Cited by 53
Self-citationAbebe, E. C., & Dejenie, T. A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1055457 · Cited by 58
Koliaki, C. C., Tentolouris, A., Eleftheriadou, I., Melidonis, A. J., Dimitriadis, G., & Tentolouris, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072288 · Cited by 56
Machine intelligence design of 2019-nCoV drugsPreprint
Gao, K., Nguyen, D. D., Wang, R., & Wei, G. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.30.927889 · Cited by 56
Liu, M., Zheng, B. J., Zhang, Y., & Li, J. (2020) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2020.05.003 · Cited by 53
Otto, D. P., & de Villiers, M. M. (2020) · Molecules · doi:10.3390/molecules25153415 · Cited by 64
Pharmacological treatments of COVID-19
Sahebnasagh, A., Avan, R., Saghafi, F., Mojtahedzadeh, M., Sadremomtaz, A., Arasteh, O., Tanzifi, A., Faramarzi, F., Negarandeh, R., Safdari, M., et al. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00152-9 · Cited by 54
Khan, N., Chen, X., & Geiger, J. D. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.595888 · Cited by 51
Kiener, M., Roldán, N., Machahua, C., Sengupta, A., Geiser, T., Guenat, O. T., Funke-Chambour, M., Hobi, N., & Julio, M. K. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.644678 · Cited by 52
Early and late endocrine complications of COVID-19
Kazakou, P., Paschou, S. Α., Ψαλτοπούλου, Θ., Gavriatopoulou, M., Korompoki, E., Stefanaki, K., Kanouta, F., Kassi, G., Dimopoulos, M. A., & Mitrakou, A. (2021) · Endocrine Connections · doi:10.1530/ec-21-0184 · Cited by 56
Burster, T., Traut, R., Yermekkyzy, Z., Mayer, K., Westhoff, M., Bischof, J., & Knippschild, U. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.695325 · Cited by 51
Toelzer, C., Gupta, K., Yadav, S. K. N., Hodgson, L. R., Williamson, M. K., Buzas, D., Borucu, U., Powers, K. T., Stenner, R., Vasileiou, K., et al. (2022) · Science Advances · doi:10.1126/sciadv.adc9179 · Cited by 49
Hulme, K. D., Noye, E. C., Short, K. R., & Labzin, L. I. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.770066 · Cited by 52
Frank, H. K., Enard, D., & Boyd, S. D. (2022) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2022.0193 · Cited by 51
Commentary: Origin and evolution of pathogenic coronaviruses
Adachi, S., Koma, T., Doi, N., Nomaguchi, M., & Adachi, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00811 · Cited by 52
Salivary diagnostics in COVID-19: Future research implications
Divya, V., & Balasubramanian, S. K. (2020) · Journal of Dental Sciences · doi:10.1016/j.jds.2020.04.006 · Cited by 51
Dysfunctional Coagulation in COVID-19: From Cell to Bedside
Wang, J., Saguner, A. M., An, J., Ning, Y., Yang, Y., & Li, G. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01399-7 · Cited by 51
Cueno, M. E., & Imai, K. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2020.594439 · Cited by 54
COVID-19: Molecular and Cellular Response
Alipoor, S. D., Mortaz, E., Jamaati, H., Tabarsi, P., Bayram, H., Varahram, M., & Adcock, I. M. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.563085 · Cited by 53
An outbreak of SARS-CoV-2 with high mortality in mink (Neovison vison) on multiple Utah farms
Eckstrand, C., Baldwin, T. J., Torchetti, M. K., Killian, M. L., Rood, K. A., Clayton, M. J., Lott, J. K., Wolking, R. M., Bradway, D. S., & Baszler, T. V. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009952 · Cited by 56
Host Cellular RNA Helicases Regulate SARS-CoV-2 Infection
Ariumi, Y. (2022) · Journal of Virology · doi:10.1128/jvi.00002-22 · Cited by 51
Protective neutralizing epitopes in SARS‐CoV‐2
Liu, H., & Wilson, I. A. (2022) · Immunological Reviews · doi:10.1111/imr.13084 · Cited by 49
Lymphocyte Changes in Severe COVID-19: Delayed Over-Activation of STING?
Berthelot, J., Lioté, F., Maugars, Y., & Sibilia, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.607069 · Cited by 53
ACE2 Nascence, trafficking, and SARS-CoV-2 pathogenesis: the saga continues
Badawi, S., & Ali, B. R. (2021) · Human Genomics · doi:10.1186/s40246-021-00304-9 · Cited by 49
Effect of Biomedical Materials in the Implementation of a Long and Healthy Life Policy
Dobrzański, L. A., Dobrzańska-Danikiewicz, A. D., & Dobrzański, L. B. (2021) · Processes · doi:10.3390/pr9050865 · Cited by 53
Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2
Shi, G., Chiramel, A. I., Li, T., Lai, K. K., Kenney, A. D., Zani, A., Eddy, A. C., Majdoul, S., Zhang, L., Dempsey, T., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci160766 · Cited by 48
Choudhury, C. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1771424 · Cited by 51
Metadata
- Authors
- Letko, M., Marzi, A., & Munster, V.
- Affiliations
- National Institutes of Health (US)
- National Institute of Allergy and Infectious Diseases (US)
- Corresponding author
- Letko, Michael
- Munster, Vincent
- Venue
- Nature Microbiology
- Published
- 2020-02-24
- Volume
- 5
- Issue
- 4
- Pages
- 562-569
- ISSN
- 2058-5276 (ISSN-L)
- PMC
- PMC7095430
- OpenAlex
- W3008394341
- Cited by
- 3,109
- References
- 38
- Citations by year
- 2026: 47 · 2025: 122 · 2024: 198 · 2023: 287 · 2022: 571 · 2021: 874 · 2020: 1002
- FWCI
- 89.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature Microbiology (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- Funders
- Chinese Center for Disease Control and Prevention
- Chinese Academy of Medical Sciences
- Peking Union Medical College
- National Institute of Allergy and Infectious Diseases
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Zoonotic diseases and public health
- Keywords
- SARS-CoV-2, SARS-CoV, cell entry, ACE2 receptor, zoonotic transmission, viral recombination, cross-species infection
- MeSH terms
- Protein Domains, Betacoronavirus, Receptors, Coronavirus, Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, Animals, Cell Line, Humans, Peptidyl-Dipeptidase A, Mutation, Pneumonia, Viral, Receptors, Virus, Recombinant Fusion Proteins, Trypsin, Coronavirus Infections, Dipeptidyl Peptidase 4, CD13 Antigens, Severe acute respiratory syndrome-related coronavirus, Virus Internalization, Pandemics, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
